![Benjamin Looker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Looker
General Counsel at
ESPERION THERAPEUTICS, INC.
Net worth: 2 M $ as of 31/05/2026
Profile
Benjamin O.
Looker is Secretary & General Counsel at Esperion Therapeutics, Inc. since 2022.
Formerly, Mr. Looker was Associate General Counsel-Oncology at Merck KGaA, General Counsel at Trillium Therapeutics, Inc. in 2021, Associate at Goodwin Procter LLP, and VP, Head-US Legal & Global Business Operations at MorphoSys US, Inc. from 2019 to 2021.
Education includes undergraduate studies at Boston College and graduate studies at Boston College Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/06/2026 | 6,67,524 ( 0.26% ) | 2 M $ | 31/05/2026 |
Benjamin Looker active positions
| Companies | Position | Start |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | General Counsel | 01/01/2022 |
Former positions of Benjamin Looker
| Companies | Position | End |
|---|---|---|
| TRILLIUM THERAPEUTICS | General Counsel | 01/11/2021 |
MorphoSys US, Inc. | General Counsel | 01/04/2021 |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
| MERCK KGAA | Corporate Officer/Principal | - |
Training of Benjamin Looker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MorphoSys US, Inc. | Health Technology |
- Stock Market
- Insiders
- Benjamin Looker
